Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis
Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis
复制标题
临床无肌病性皮肌炎患者快速进展性间质性肺疾病的预测因素
DOI:
10.1007/s10067-015-3139-z
复制
发表时间:
2016-01-01
影响因子:
3.4
通讯作者:
Yang, P. T.
中科院分区:
文献类型:
--
作者:
Xu, Y.;Yang, C. S.;Yang, P. T.
Clinically amyopathic dermatomyositis (CADM) is a unique subset of dermatomyositis, showing a high incidence of lung involvements. The aim of this study is to identify risk factors, other than melanoma differentiation-associated protein (MDA)-5, for developing rapidly progressive-interstitial lung disease (RP-ILD) in patients with CADM. Forty CADM patients, in whom 11 patients developed RP-ILD, were enrolled. Clinical features and laboratory findings were compared between the patients with and without RP-ILD. We found that skin ulceration, CRP, serum ferritin, anti-MDA5 Ab, and lymphocytopenia were significantly associated with ILD. Multivariate logistic regression analysis indicated that anti-MDA5 Ab+, elevated CRP, and decreased counts of lymphocyte were independent risk factors for RP-ILD, which can provide a precise predict for RP-ILD in CADM patients. When anti-MDA5 Ab+was removed from the multivariate regression model, using skin ulcerations, elevated serum ferritin and decreased counts of lymphocyte can also precisely predict RP-ILD. Except for MDA-5, more commonly available clinical characteristics, such as skin ulcerations, serum ferritin, and count of lymphocyte may also help to predict prognosis in CADM.